{"id":973031,"date":"2026-06-17T07:33:35","date_gmt":"2026-06-17T11:33:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/"},"modified":"2026-06-17T07:33:35","modified_gmt":"2026-06-17T11:33:35","slug":"trevi-therapeutics-announces-upcoming-june-and-july-event-schedule","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/","title":{"rendered":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW HAVEN, Conn., June  17, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=i6d6FfCBs_DpYb4LZ6P-goHqvlNhDNBQBoaWg2uCKy16RI5dhIdozi6ByGptHE-EDScu3ensm8383fqN766Z2tqFxruFUuMI8Tp0hveaYeIpI_5IhbbUtp4_cd5xO3Ky\" rel=\"nofollow\" target=\"_blank\"><u>Trevi Therapeutics, Inc.<\/u><\/a>\u00a0(Nasdaq: TRVI),\u00a0a clinical-stage biopharmaceutical company developing the investigational\u00a0therapy\u00a0Haduvio\u2122\u00a0(oral nalbuphine ER)\u00a0for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD),\u00a0and refractory chronic cough (RCC),\u00a0today announced that senior management will attend several upcoming events\u00a0in June and July.\u00a0\u00a0<\/p>\n<p>\n        <strong><br \/>\n          <u>BIO International Convention <\/u><br \/>\n        <\/strong><br \/>\n        <br \/>June 22-25, 2026, San Diego, California<br \/><strong>Trevi Representatives:<\/strong><strong>\u00a0<\/strong>Jennifer Good, President and CEO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0<\/p>\n<p>\n        <strong><br \/>\n          <u>Leerink Partners Therapeutics Forum 2026<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>July 14-15, 2026, Boston, Massachusetts <br \/><strong>Trevi Representatives:<\/strong> David Hastings, CFO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0<\/p>\n<p>\n        <strong><br \/>\n          <u>ERS\u00a0Cough Conference 2026<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>July 15-17, 2026, London, United Kingdom <br \/><strong>Trevi Representatives:<\/strong> Jennifer Good, President and CEO,\u00a0and\u00a0James Cassella, Ph.D., CDO<\/p>\n<p>\n        <strong>About Trevi Therapeutics, Inc.<\/strong><br \/>\n        <strong>\u00a0<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio\u2122 (oral nalbuphine extended-release) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC). Haduvio is the first and only investigational therapy to show a\u00a0statistically-significant\u00a0reduction in cough frequency in clinical trials across\u00a0both patients\u00a0with IPF-related chronic cough and in patients with RCC. Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), targeting opioid receptors that play a key role in controlling chronic cough. Nalbuphine is not currently scheduled by the U.S. Drug Enforcement Agency.\u00a0\u00a0\u00a0<\/p>\n<p>Chronic\u202fcough\u202fin patients with IPF and non-IPF ILD is a condition with high unmet need and no FDA-approved therapies. There are ~140,000 U.S. patients with IPF, and two-thirds of these patients are faced with uncontrolled chronic cough. Additionally, there are ~228,000 U.S. patients with non-IPF ILD, with 50-60% having uncontrolled chronic cough. The impact of chronic cough is significant, with patients coughing up to 1,500 times per day. This consistent cough, and any associated damage, may lead to a higher risk of morbidity and mortality, including worsening disease, a higher risk of progression, increased respiratory hospitalizations, and a decline in patients&#8217; quality of life.\u202f\u00a0\u202f\u202f\u202f\u202f\u00a0<br \/>\u202f\u202f\u202f\u00a0<br \/>RCC is a condition with high unmet need and no FDA-approved therapies. RCC is defined as a persistent cough lasting &gt;8\u2005weeks despite treatment for an underlying condition (i.e., asthma, gastroesophageal reflux disease, non-asthmatic eosinophilic bronchitis, upper airway cough syndrome, or post-nasal drip) and includes unexplained chronic cough. There are ~2-3 million U.S. patients with RCC, and it is believed to be associated with cough reflex hypersensitivity involving both the central and peripheral nervous systems. RCC is highly debilitating and may impact patients physically, psychologically, and socially. \u00a0<\/p>\n<p>Trevi intends to propose Haduvio as the trade name for oral nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority.<\/p>\n<p>For more information, visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UjAaIfneC1LTEbdcCTbAaSWxkSqRbkYaGSLPAjCe3zLVMTaJhgEjqYChbGcOUUNjKoR8rhfB9NcxhNls2ydyhDB60YkCeVMQVSSlrAYk8xwdBzHUhHYU95wZQakIT7rW\" rel=\"nofollow\" target=\"_blank\"><u>www.TreviTherapeutics.com<\/u><\/a>\u202fand follow Trevi on\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Kbv58Pvi9lmNb0z5A3Ml6rN-iqqp33UVWS2KEF2dIKF1JytsliY8WLlgQn90nYOxfytc7Daqom2m6E1Eb_sw2g==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>\u202f(formerly Twitter) and\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CXHt0-E_YTwdago1ZVmj0TWP3gtwPWJXZvDQYo04tmDPKeAFMVM0uuNVNqvE_znzNOqjkWV5fu4ukR05HY5BXh_eXEbNAE3-0tC3U-QEc9PY3KCuOzfLvFq9mL6AhiJQ\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Jonathan Carlson\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Trevi Therapeutics,\u00a0Inc.\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>(203) 654 3286\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hZYKf3KSmiJOk4rWo1NORT1hQRdk3nAsBVY0B0zlc1HXCaC2l8s7fOI8vYXiqnPHgy0zVHl6BUgierSn9ccs6A==\" rel=\"nofollow\" target=\"_blank\"><u>IR@trevitx.com<\/u><\/a>\u00a0\u00a0<br \/>\u00a0\u00a0<br \/><strong>Media\u00a0Contact<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Rosalia Scampoli\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>914-815-1465\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fzvBnAkhm3Klq8twr0yPGgG7-n4nhLtAeYuVo4k1KPkPIbLMTl13bn6JY1A5UZIPL0u9MXYhaEYGNtr84Ygakq5xj3wswJxiuXkF8iMV5HKl0A88K6rcX7II5sHTifAD\" rel=\"nofollow\" target=\"_blank\"><u>rscampoli@marketcompr.com<\/u><\/a>\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjQ5YThkMGQtMDEzMC00NGRhLTlkZGQtYWI4ZTZmMTBjYzVkLTExMzY2ODctMjAyNi0wNi0xNy1lbg==\/tiny\/Trevi-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Trevi Therapeutics, Inc.\u00a0(Nasdaq: TRVI),\u00a0a clinical-stage biopharmaceutical company developing the investigational\u00a0therapy\u00a0Haduvio\u2122\u00a0(oral nalbuphine ER)\u00a0for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD),\u00a0and refractory chronic cough (RCC),\u00a0today announced that senior management will attend several upcoming events\u00a0in June and July.\u00a0\u00a0 BIO International Convention June 22-25, 2026, San Diego, CaliforniaTrevi Representatives:\u00a0Jennifer Good, President and CEO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 Leerink Partners Therapeutics Forum 2026 July 14-15, 2026, Boston, Massachusetts Trevi Representatives: David Hastings, CFO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 ERS\u00a0Cough Conference 2026 July 15-17, 2026, London, United Kingdom Trevi Representatives: Jennifer Good, President and CEO,\u00a0and\u00a0James Cassella, Ph.D., CDO About Trevi Therapeutics, Inc. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-973031","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Trevi Therapeutics, Inc.\u00a0(Nasdaq: TRVI),\u00a0a clinical-stage biopharmaceutical company developing the investigational\u00a0therapy\u00a0Haduvio\u2122\u00a0(oral nalbuphine ER)\u00a0for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD),\u00a0and refractory chronic cough (RCC),\u00a0today announced that senior management will attend several upcoming events\u00a0in June and July.\u00a0\u00a0 BIO International Convention June 22-25, 2026, San Diego, CaliforniaTrevi Representatives:\u00a0Jennifer Good, President and CEO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 Leerink Partners Therapeutics Forum 2026 July 14-15, 2026, Boston, Massachusetts Trevi Representatives: David Hastings, CFO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 ERS\u00a0Cough Conference 2026 July 15-17, 2026, London, United Kingdom Trevi Representatives: Jennifer Good, President and CEO,\u00a0and\u00a0James Cassella, Ph.D., CDO About Trevi Therapeutics, Inc. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical &hellip; Continue reading &quot;Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-17T11:33:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0\",\"datePublished\":\"2026-06-17T11:33:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/\"},\"wordCount\":504,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/\",\"name\":\"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\",\"datePublished\":\"2026-06-17T11:33:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/","og_locale":"en_US","og_type":"article","og_title":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk","og_description":"NEW HAVEN, Conn., June 17, 2026 (GLOBE NEWSWIRE) &#8212; Trevi Therapeutics, Inc.\u00a0(Nasdaq: TRVI),\u00a0a clinical-stage biopharmaceutical company developing the investigational\u00a0therapy\u00a0Haduvio\u2122\u00a0(oral nalbuphine ER)\u00a0for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD),\u00a0and refractory chronic cough (RCC),\u00a0today announced that senior management will attend several upcoming events\u00a0in June and July.\u00a0\u00a0 BIO International Convention June 22-25, 2026, San Diego, CaliforniaTrevi Representatives:\u00a0Jennifer Good, President and CEO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 Leerink Partners Therapeutics Forum 2026 July 14-15, 2026, Boston, Massachusetts Trevi Representatives: David Hastings, CFO, and\u00a0Farrell Simon, Pharm.D.,\u00a0CCO\u00a0\u00a0 ERS\u00a0Cough Conference 2026 July 15-17, 2026, London, United Kingdom Trevi Representatives: Jennifer Good, President and CEO,\u00a0and\u00a0James Cassella, Ph.D., CDO About Trevi Therapeutics, Inc. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical &hellip; Continue reading \"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-17T11:33:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0","datePublished":"2026-06-17T11:33:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/"},"wordCount":504,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/","name":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=","datePublished":"2026-06-17T11:33:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0Nzk2MSM3NjY0NTU0IzIxMjUxMTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevi-therapeutics-announces-upcoming-june-and-july-event-schedule\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Trevi Therapeutics Announces Upcoming June and July Event Schedule\u00a0\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=973031"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/973031\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=973031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=973031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=973031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}